Clinical Evaluation of a Photon Counter Computer tomograph (Photon-Counting CT)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017759

Enrollment

100

Registered

2019-08-22

Start date

2019-07-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90 J84

Interventions

Group 1: - multiple myeloma: examination of focal myeloma lesions in the lumbar spine or pelvis - Osteoplastic bone metastases: Examination of osteoplastic metastases in the lumbar spine or pelvis -

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age over 18 years - Performance Status 0-2 - written agreement to conduct the study

Exclusion criteria

Exclusion criteria: Rejection by the patient - Age under 18 years - Lack of ability to consent - Pregnant / nursing mothers

Design outcomes

Primary

Measure	Time frame
In this study, the clinical benefit of the technical advantages of PC-CT will be evaluated. Hypotheses for subsequent studies will be generated for a defined number of disease entities.	—

Secondary

Measure	Time frame
The clinical benefit of the technical advantages of PC-CT will be evaluated in an exploratory study. Small patient groups (<10) are to be examined for several disease entities.	—

Countries

Germany

Contacts

Public ContactVanessa Peregovich

Deutsches Krebsforschungszentrum (DKFZ)

v.peregovich@dkfz-heidelberg.de+49 6221 42 2622

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026